Your session is about to expire
← Back to Search
Long-Term Follow-Up of P-BCMA-101 for Multiple Myeloma
Study Summary
This trial will follow subjects for 15 years to assess long-term safety and effectiveness of P-BCMA-101 T cells. Rimiducid may be given as needed.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- N/AYou have already taken P-BCMA-101 as part of another study sponsored by Poseida and either finished or stopped early.
- Group 1: P-BCMA-101 treated
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this therapy backed by any prior experimental investigations?
"Currently, 16 trials are running that aim to assess the efficacy of this treatment with none reaching Phase 3 yet. Even though most studies take place in Nashville, Tennessee, 94 different sites across the country have joined these investigations."
How many participants have thus far volunteered for the clinical trial?
"This clinical trial has unfortunately ended its recruitment period. It was posted on October 29th 2018 and the last update occurred June 30th 2022, rendering it no longer available for patient registration. However, 805 other studies related to multiple myeloma are still actively seeking participants, 16 of which involve this specific treatment."
Are there still openings available to join this clinical trial?
"According to the clinicaltrials.gov database, this trial is not currently open for recruitment. It was initially posted on October 29th 2018 and its most recent update occurred on June 30th 2022. Although this study does not require new candidates at present, 821 other trials are actively seeking participants now."
Has this medical experiment been extended to various facilities across North America?
"This clinical trial is currently underway at 16 distinct sites, including San Diego, Hackensack and Gilbert. To reduce the strain of travel on participants, it is important to select a location close to their residence if they decide to enroll."
Has this therapeutic intervention been sanctioned by the Federal Drug Administration?
"Due to the limited amount of data available on safety and efficacy, this treatment has been rated as a 1 in terms of security."
Share this study with friends
Copy Link
Messenger